Carbamazepine in the treatment of cocaine dependence: subtyping by affective disorder.

Abstract

Studies investigating carbamazepine (CBZ) in the treatment of cocaine dependence have been inconsistent. In this study, cocaine-dependent individuals with (n = 57) and without (n = 82) affective disorder were compared in a 12-week, double-blind, placebo-controlled trial. Urine drug screens (UDS) and self-report of drug use were collected weekly. Affective symptoms were measured monthly. Subjects receiving CBZ attended more medication sessions (p = .03). The CBZ-treated affective group had a trend toward fewer cocaine-positive UDS (p = .08) and a significantly longer time to first cocaine use (p = .06). CBZ treatment did not have any impact on cocaine use in individuals without affective disorders.

Statistics

0100200300'05'06'07'08'09'10'11'12'13'14'15'16'17
Citations per Year

339 Citations

Semantic Scholar estimates that this publication has 339 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Brady2002CarbamazepineIT, title={Carbamazepine in the treatment of cocaine dependence: subtyping by affective disorder.}, author={Kathleen T. Brady and Susan C. Sonne and Robert J. Malcolm and Carrie L. Randall and Bonnie S Dansky and Kit N. Simpson and J. Steven Roberts and Michael J Brondino}, journal={Experimental and clinical psychopharmacology}, year={2002}, volume={10 3}, pages={276-85} }